Cite
Impact of rewarming rate on interleukin-6 levels in patients with shockable cardiac arrest receiving targeted temperature management at 33 °C: the ISOCRATE pilot randomized controlled trial
MLA
Jean-Baptiste Lascarrou, et al. “Impact of Rewarming Rate on Interleukin-6 Levels in Patients with Shockable Cardiac Arrest Receiving Targeted Temperature Management at 33 °C: The ISOCRATE Pilot Randomized Controlled Trial.” Critical Care, vol. 25, no. 1, Dec. 2021, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s13054-021-03842-9.
APA
Jean-Baptiste Lascarrou, Elie Guichard, Jean Reignier, Amélie Le Gouge, Caroline Pouplet, Stéphanie Martin, Jean-Claude Lacherade, Gwenhael Colin, & AfterROSC network. (2021). Impact of rewarming rate on interleukin-6 levels in patients with shockable cardiac arrest receiving targeted temperature management at 33 °C: the ISOCRATE pilot randomized controlled trial. Critical Care, 25(1), 1–11. https://doi.org/10.1186/s13054-021-03842-9
Chicago
Jean-Baptiste Lascarrou, Elie Guichard, Jean Reignier, Amélie Le Gouge, Caroline Pouplet, Stéphanie Martin, Jean-Claude Lacherade, Gwenhael Colin, and AfterROSC network. 2021. “Impact of Rewarming Rate on Interleukin-6 Levels in Patients with Shockable Cardiac Arrest Receiving Targeted Temperature Management at 33 °C: The ISOCRATE Pilot Randomized Controlled Trial.” Critical Care 25 (1): 1–11. doi:10.1186/s13054-021-03842-9.